In a sign that its recent regard for restraint is prevailing, the Roberts court is signaling that it’ll take a narrow approach on mifepristone.
Matt Ford
December 14, 2023
The Supreme Court announced on Wednesday that it would take up its first abortion-related case since overturning Roe v. Wade last year. Abortion rights groups could not have asked for a better start to it.
In its latest batch of orders, the court said it would take up FDA v. Alliance for Hippocratic Medicine and Danco Laboratories v. Alliance for Hippocratic Medicine. The consolidated appeals, which all stem from the same original lawsuit, seek to overturn a federal court’s ruling in Texas that, if allowed to take effect, would overturn recent Food and Drug Administration rule changes that made the most widely used abortion pill easier to prescribe and obtain.
Continued: https://newrepublic.com/article/177580/supreme-court-narrow-mifepristone-standing